Company Profile
Kubota Pharmaceutical provides the pharmaceutical and medical device business globally. The company offers eyeMO, a remote retinal monitoring device for home-based and patient self-monitoring optical coherence tomography; and a NASA high-res version OCT device
Emixustat HCI compounds for Stargardt disease indications in Phase 3 clinical trials, as well as proliferative diabetic retinopathy and diabetic macular edema in Phase 2 clinical trials. Founded in 2002, the company is headquartered in Minato, Japan.